Raymond James Reinstates Outperform on CareTrust REIT, Announces $43 Price Target
Benzinga Newsdesk 4 months ago
NewsPrice TargetInitiationAnalyst Ratings
Raymond James analyst David Rodgers reinstates CareTrust REIT (NYSE:CTRE) with a Outperform and announces $43 price target.
Raymond James analyst David Rodgers reinstates CareTrust REIT (NYSE:CTRE) with a Outperform and announces $43 price target.